Get help finding a supplier  

Supplier Type of Service Brief Description
An (*) indicates a supplier offering a discount for COVID-19 related services and/or products.
Advanced Cell Diagnostics, Inc. Assay Services RNAscope services to visualize the SARS-Cov-2 viral RNA and detect viral replication, visualize cellular receptor ACE2 and proteases such as TMPRSS2 and Cathepsin B and L, identify cellular sources of IL-1β, IL-6, IL-8, TNFα and IL-10 which can induce Acute Respiratory Distress Syndrome (ARDS) in severe SARS-CoV-2 (COVID-19) patients
Applied Pathology Systems* Assay Services Histology and pathology services such as H&E stain, special stains, IHC stain, antibody validation, digital imaging, whole slide scanning, pathology evaluation/assesment to support SARS-2-CoV (COVID-19) research. Have supply control tissue slides for the different stains and FFPE samples with detailed annotated clinical data.
Araneae Biotech Consulting LLC* Assay Services Offers consulting services in life science industry spanning devices, drugs, veterinary products, and diagnostics.
BioAssay Systems Assay Services Offer assay development services and are prioritizing SARS-CoV-2 (COVID-19) related services and assay kits.
Boca Biolistics Assay Services Launched BBL SARS-CoV-2 (COVID-19) Validation Panel. The BBL SARS-CoV-2 panel will consist of non-contrived native human material, 30 positive and 30 negative NP/OP specimens characterized and designed for use on the Hologic Panther Fusion SARS-CoV-2 (COVID-19) Test. In addition, can provide Human BIological Samples from SARS-CoV-2 (COVID-19) patients.
Cyclolab* Assay Services Offering formulation development mainly based on cyclodextrins (remdesivir is also cyclodextrin-enabled) assistance. Is ready to evaluate any antiviral small molecule candidate with limited water solubility to understand if cyclodextrins are a viable solution to reach the target concentration.
Daxor* Assay Services Provides a blood volume analyzer BVA-100 optimizes resuscitation in patients with ARDS, respiratory distress, septic shock etc to reduce time on ventilator, reduce ICU mortality etc. Electronmicroscopic Inc. (EMSCOPIC) analyze viral-cell interactions specifically shown to work in SARS-CoV-2 (COVID-19) host-pathogen interactions
Epithelix Assay Services A platform, based on fully differentiated in vitro 3D human airway epithelia, is now ready for evaluating antiviral drugs or therapeutic strategies against SARS-CoV-2 (COVID-19) infection. Additionally now testing for antiviral activity against currently circulating SARS-CoV-2 (COVID-19) isolated from patients.Test are performed either monitoring antiviral activity delivered systemically or airborne.
FlowKnowHow LLC* Assay Services Provides flow cytometry services as well as assitance with analyzing data, generating graphics, drawing up reports, etc for SARS-CoV-2 (COVID-19) related research projects.
Horizon Discovery Assay Services Study the function of human genes involved in cellular entry and host-pathogen interaction using siRNA, CRISPR, Knockout cell models, genomic screening services. Additionally SARS-CoV-2 (COVID-19) diagnostic tools, and ACE2 related research tools available
Hybrigenics Services SAS* Assay Services Y2H screening services as well as synthetic nanobody services dedicated to the study of protein interactions and target identification for drugs.
IBT Bioservices Assay Services Developing a neutralization assay using pseudotyped-VSV-CoV-19 that is replication incompetent in addition to reagents related to SARS-CoV-2 (COVID-19) viral proteins, host receptors, and related targets.
Immundnz Assay Services SARS-CoV-2 (COVID-19) testing for asymptomatic/Cat-2 compliant specimens, and research for the development of diagnosis or treatment. In addition to various in vitro human models and assays in lung cell biology that may contribute to the better understanding of adverse effects of the virus.
InSphero* Assay Services Free safety testing for exploratory SARS-COV-2 (COVID-19) medications and vaccine formulations. These SARS-COV-2 (COVID-19) tests will be based on InSphero‘s 3D InSight™ Human Liver models and available to any organization (academic, governmental or industrial) that wants to test their treatments in development.
Krishgen Biosystems Assay Services Recombinat Nucleocapsid protein, host cell receptor proteins, IgG and IgM Rapid ELISA kits, Cytokine Storm ELISA KITs, and RT-PCR kits for SARS-CoV-2 (COVID-19) research
Nexelis (formerly PAIRimmune)* Assay Services In vivo immunogenicity models, In vivo challenge models (through our partners at PHE), ELISA assays for multiple antigens, Pseudo-virion based neutralization assay. HCoV assays for strains 229E or OC43.
NorthEast BioLab* Assay Services SARS-CoV-2 (COVID-19) related Ligand Binding Assay (LBA) Development and Multiplex testing
Olink Proteomics AB* Assay Services Prioritizing SARS-CoV-2 (COVID-19) research projects for biomarker panels
R&D Systems Assay Services SARS-CoV-2 (COVID-19) cytokine panel (1-hour immunoassay) for inflammation targets used by Mount Sinai (NY) and Spallanzani Hospital & National Institute for Infectious Diseases in Italy (Rome). Additionally, provide an immunoassay platform, Ella platform, and a rapid serology IgG/IgM COVID-19 from our Novus Biological platform
RayBiotech Assay Services Detection SARS-CoV-2 (COVID-19) N-Protein IgM / IgG antibodies in human finger prick samples, as well as serum, plasma, and whole blood. Offers SARS-CoV-2 (COVID-19) related proteins, antibodies, cytokine arrays, biomarker assays, and ELISAs.
Reveal Biosciences Assay Services Cell and Tissue Histology services including image analysis for those working with SARS-CoV-2 (COVID-19).
Simulations Plus, Inc.* Assay Services StrategiesPlus™ COVID-19 ACT Program, provide “immediate support” for research efforts to help address the SARS-CoV-2 (COVID-19) virus. GastroPlus®, the only validated, mechanistic PBBM/PBPK lung model, to investigate alternative dosing modalities (inhalation, oral, and various parenteral routes) and optimize dosing to target lung exposure
StemCellerant Assay Services iPSC-based assay for human lung cells in response to COVID so researchers can screen therapeutics and model the disease.
Texcell Assay Services Working with an Italian isolate of SARS-CoV-2 (COVID-19) for assay development services. Testing the virucidal effect of manufacturered disinfectants on a surrogate for the new SARS-CoV-2 (COVID-19).
Unchained Labs* Assay Services Tools for vaccine and drug development
Venomtech Ltd* Assay Services Offering a targeted venom discovery array
Virology Research Services Ltd Assay Services Developing assays for human coronaviruses 229E, OC43, and NL63; we anticipate to have these assays running by the end of April. Currently can test compounds against COVID-19 through a subcontractor, using a CPE-based assay.
Visikol Inc* Assay Services Priority for SARS-CoV-2 (COVID-19) projects so they are first to get completed in our lab
Wuxi Biortus Biosciences Co. Ltd. Assay Services Providing production of virus-related proteins, assay development and screening based on fragment libraries along with many biochemical and biophysical analysis, structure determination of virus proteins via X-ray crystallography and cryoEM.
zPredicta Assay Services In response to COVID-19, zPREDICTA is developing a human airway screening platform to identify agents with antiviral activity. Can be contacted at
Twist Bioscience Assay Services Currently offering SARS-CoV-2 Research Panels and Synthetic SARS-CoV-2 RNA Controls
PhenoSwitch Bioscience* Assay Services 1st project at same price they normally have for the same service level. Utilize expertise at use and make data analysis support, consulting and project management at low cost or provide a package of free of charge hours.
PhenoVista Biosciences* Assay Services PhenoVista offers high content imaging services to further SARS-CoV-2 (COVID-19) research, including assays for viral uptake, organelle localization, autophagy and drug re-purposing.
Protavio Ltd (UK)/ProtATonce (GR) Assay Services Luminex assays for diagnosing immunity to SARS-CoV-2 (COVID-19), MERS & SARS (IgM/IgG).
Gifford Bioscience Assay Services Radiometric and SPR (Biacore) assays for SARS-CoV-2 spike protein : ACE2 interaction. The competitive radioligand binding assay can be used to test for the ability of neutralizing antibodies and other therapeutic agents to disrupt the spike protein : ACE2 binding in crude cell and tissue homogenates. The non-radiometric SPR (Biacore) assay performs the same test on the purified ACE2 protein captured onto a streptavidin-coated sensor chip.
Wax-it Histology Services Inc Assay Services Histopathology and Immunohistochemistry services related to SARS-CoV-2 (COVID-19 research. Assay Services attyloid is looking for partners interested in SARS-CoV-2 particle analytics for - absolute titer determination - decontamination studies - neutralisation assays - seroconversion assays
Arctoris Assay Services Arctoris offers fully validated biochemical assays for COVID-19 including Mpro (3CL), PLpro, Spike - ACE2. Our assays are of extremely high standard (Z' > 0.8) and are operated with total automation of the experiment and the data processing. We offer routine potency/affinity and selectivity profiling, kinetics and mechanistic studies. We can offer turnaround times of under 24 h, and are committed to providing affordable research services to scientists in academia, biotech and pharma alike. Expedite drug discovery with total, end-to-end automation of your research.
Integral Molecular Assay Services Antibody specificity profiling rapidly tests for off-target binding of SARS-CoV-2 antibodies. Antibodies are tested against a panel of 6,000 native conformation human membrane proteins to deliver an IND-ready report with a turnaround time of approximately 4 weeks.
Integral Molecular Assay Services Conformational Epitope Mapping for SARS-CoV-2 spike protein antibodies provides single amino acid resolution epitope data using a comprehensive alanine scan library. Epitope maps inform lead selection and mechanism of action, help predict escape mutants and strengthen intellectual property. Expedited service with a turnaround time of approximately 4 weeks.
Crux Biolabs Assay Services Experts at developing & validating protein, antibody & in vitro cell assays, including PBMC isolation, for clinical and pre-clinical studies. ISO 17025 accredited BSL-2 lab in Melbourne, Australia.
Eurofins Discovery Assay Services The immune response is a central player in the recovery from, and exacerbation of, infectious disease. Human-centric, in vitro assays and physiological models that capture relevant inflamed tissue and immunomodulatory biology are critical to advance high potential treatments for the sequelae of viral infection. These models serve a variety of strategies from discovery to repurposing, and from individual to combination therapies. Validated against clinical compounds, Eurofins Discovery Phenotypic Center of Excellence Cell-based Immune Response Models provide reproducible data, actionable insights, and a smooth transition into our broader portfolio of services.
Eurofins Discovery Assay Services Take a human-centered, unbiased approach to drug discovery. Phenotypic profiling and screening allows you to capture the activity of multiple targets and pathway mechanisms in physiologically relevant, in vitro disease models. We've been a global leader in human phenotypic drug discovery services since 2000—advancing candidate pipelines for nearly 500 clients. Learn more about our portfolio of offerings, including Custom Services. We’re here to help!